Management cited potential unevenness in commercial loan losses and elevated delinquencies due to a few specific loans but expressed confidence in collateral and recourse levels. The impact of ...
Robert Ford, Chairman and CEO, reported organic sales growth of 7.5% excluding COVID test sales, highlighting double-digit growth in Medical Devices and high single-digit growth in Established ...
The company expects consolidated fourth quarter net sales to decrease 10% to 15% sequentially, with adjusted EBITDA between $130 million and $160 million. Full year 2025 sales are anticipated between ...
Ten big names clocked in double-digit gains on Monday, mirroring a broader market rally, as investor optimism was fueled by a flurry of macroeconomic developments, including continued momentum in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results